Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Joe Wesley who wrote (2176)	5/11/1999 11:43:00 PM
From: Steve Harmon	Respond to of 2742

Thanks for the research. At .20 none of our assets are in the current price of Cistron's stock. As I am sure you know. Steve

To: Joe Wesley who wrote (2176)	5/12/1999 7:48:00 PM
From: Walter Morton	Read Replies (1) \| Respond to of 2742

"...plans to disassociate the adjuvant effect from the inflammatory effect..." It seems like that will be a tough goal to achieve, but a good idea. I have read more abstracts about IL-1b that make it seem more harmful that helpful.